{"protocolSection":{"identificationModule":{"nctId":"NCT01703663","orgStudyIdInfo":{"id":"U037625"},"organization":{"fullName":"University of Michigan","class":"OTHER"},"briefTitle":"Nasal EPAP for Stroke Patients With Sleep Apnea: a Pilot Trial.","officialTitle":"Nasal EPAP for Stroke Patients With Sleep Apnea: a Pilot Trial."},"statusModule":{"statusVerifiedDate":"2016-08","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2012-11"},"primaryCompletionDateStruct":{"date":"2015-04","type":"ACTUAL"},"completionDateStruct":{"date":"2015-04","type":"ACTUAL"},"studyFirstSubmitDate":"2012-10-05","studyFirstSubmitQcDate":"2012-10-05","studyFirstPostDateStruct":{"date":"2012-10-10","type":"ESTIMATED"},"resultsFirstSubmitDate":"2016-05-19","resultsFirstSubmitQcDate":"2016-08-19","resultsFirstPostDateStruct":{"date":"2016-10-13","type":"ESTIMATED"},"lastUpdateSubmitDate":"2016-08-19","lastUpdatePostDateStruct":{"date":"2016-10-13","type":"ESTIMATED"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"Devin Brown","investigatorTitle":"Professor","investigatorAffiliation":"University of Michigan"},"leadSponsor":{"name":"University of Michigan","class":"OTHER"}},"oversightModule":{"oversightHasDmc":false},"descriptionModule":{"briefSummary":"Specific aim: To test the effects of nasal expiratory positive airway pressure (EPAP) therapy on sleep apnea severity among patients with recent ischemic stroke.\n\nHypothesis 1: Ischemic stroke patients with sleep apnea will have less severe sleep apnea, as measured by the apnea-hypopnea index (AHI), with nasal EPAP therapy compared with a control night.\n\nHypothesis 2: Ischemic stroke patients will have higher mean levels of oxygen saturation with nasal EPAP therapy compared with a control night."},"conditionsModule":{"conditions":["Ischemic Stroke","Obstructive Sleep Apnea"],"keywords":["Stroke","Sleep Apnea"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"CROSSOVER","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":40,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"EPAP","type":"EXPERIMENTAL","description":"Provent Sleep Apnea Therapy.","interventionNames":["Device: EPAP"]},{"label":"control","type":"NO_INTERVENTION"}],"interventions":[{"type":"DEVICE","name":"EPAP","armGroupLabels":["EPAP"],"otherNames":["Provent Sleep Apnea Therapy."]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Apnea-hypopnea Index","description":"Apnea-hypopnea index (AHI) is the sum of the apneas and hypopneas and divided by the hours of sleep based on actigraphy. AHI values are typically categorized as 5-15/hr = mild; 15-30/hr = moderate; and \\>= 30/h = severe. The prespecified primary (absolute) treatment effect is based on the linear repeated measures model.","timeFrame":"night 1 and night 2"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* adults with an ischemic stroke (including TIA with infarction) within the prior 14 days\n\nExclusion Criteria:\n\n1. Current use of any transnasal tube (eg dobhoff tube)\n2. Current use of CPAP, mechanical ventilation, or supplemental oxygen\n3. Known severe breathing disorders including hypercapnic respiratory failure, respiratory muscle weakness, bullous lung disease, bypassed upper airway, pneumothorax, pneumomediastinum\n4. Severe heart disease (including severe heart failure)\n5. Pathologically low blood pressure\n6. An acute upper respiratory (including nasal, sinus or middle ear) inflammation or infection, or perforation of the ear drum\n7. Sores, abrasions, or skin or mucosal irritation on or around the nose.\n8. Known pregnancy\n9. Inability to provide informed consent\n10. Use of alpha blockers or short acting nitrates\n11. Permanent pacemaker\n12. Sustained non-sinus cardiac arrhythmia","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Devin L Brown, MD","affiliation":"University of Michigan","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"University of Michigan","city":"Ann Arbor","state":"Michigan","zip":"48109","country":"United States","geoPoint":{"lat":42.27756,"lon":-83.74088}}]},"referencesModule":{"references":[{"pmid":"27306393","type":"DERIVED","citation":"Wheeler NC, Wing JJ, O'Brien LM, Hughes R, Jacobs T, Claflin E, Chervin RD, Brown DL. Expiratory Positive Airway Pressure for Sleep Apnea after Stroke: A Randomized, Crossover Trial. J Clin Sleep Med. 2016 Sep 15;12(9):1233-8. doi: 10.5664/jcsm.6120."}]}},"resultsSection":{"participantFlowModule":{"recruitmentDetails":"Some subjects were discharged from the hospital between the first and second night and therefore dropped out.","groups":[{"id":"FG000","title":"EPAP Therapy First Night, Then Control Night","description":"During the first night, the subject was assigned to wear EPAP. During the second night, the subject did not wear EPAP (control night). During both nights, sleep disordered breathing was monitored with the WatchPAT device."},{"id":"FG001","title":"Control Night First Night, EPAP Therapy Second Night","description":"During the first night, the subject was assigned to no EPAP (control night). During the second night, the subject was assigned to wear EPAP. During both nights, sleep disordered breathing was monitored with the WatchPAT device."}],"periods":[{"title":"First Treatment Period","milestones":[{"type":"STARTED","achievements":[{"groupId":"FG000","numSubjects":"20"},{"groupId":"FG001","numSubjects":"20"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"20"},{"groupId":"FG001","numSubjects":"20"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"}]}]},{"title":"Second Treatment Period","milestones":[{"type":"STARTED","achievements":[{"groupId":"FG000","numSubjects":"11"},{"groupId":"FG001","numSubjects":"8"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"11"},{"groupId":"FG001","numSubjects":"8"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"}]}]}]},"baselineCharacteristicsModule":{"populationDescription":"All subjects who completed both nights","groups":[{"id":"BG000","title":"All Participants"}],"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"19"}]}],"measures":[{"title":"Age, Continuous","paramType":"MEDIAN","dispersionType":"INTER_QUARTILE_RANGE","unitOfMeasure":"years","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"60","lowerLimit":"55","upperLimit":"70"}]}]}]},{"title":"Sex: Female, Male","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Female","measurements":[{"groupId":"BG000","value":"7"}]},{"title":"Male","measurements":[{"groupId":"BG000","value":"12"}]}]}]},{"title":"Body mass index, self reported","paramType":"MEDIAN","dispersionType":"INTER_QUARTILE_RANGE","unitOfMeasure":"kg/m^2","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"29.1","lowerLimit":"26.6","upperLimit":"33.5"}]}]}]},{"title":"NIH Stroke Scale","description":"total (range 0-42; 0 is no findings)","paramType":"MEDIAN","dispersionType":"INTER_QUARTILE_RANGE","unitOfMeasure":"units on a scale","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"4","lowerLimit":"2","upperLimit":"6"}]}]}]}]},"outcomeMeasuresModule":{"outcomeMeasures":[{"type":"PRIMARY","title":"Apnea-hypopnea Index","description":"Apnea-hypopnea index (AHI) is the sum of the apneas and hypopneas and divided by the hours of sleep based on actigraphy. AHI values are typically categorized as 5-15/hr = mild; 15-30/hr = moderate; and \\>= 30/h = severe. The prespecified primary (absolute) treatment effect is based on the linear repeated measures model.","reportingStatus":"POSTED","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","unitOfMeasure":"apneas plus hypopneas per hour","timeFrame":"night 1 and night 2","groups":[{"id":"OG000","title":"EPAP Night","description":"Raw data from EPAP night (not taking into account period effect)."},{"id":"OG001","title":"Control Night","description":"Raw data from control night (not taking into account period effect)."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"19"},{"groupId":"OG001","value":"19"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"17.1","lowerLimit":"13.2","upperLimit":"26.5"},{"groupId":"OG001","value":"25.2","lowerLimit":"14.2","upperLimit":"49.6"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"testedNonInferiority":false,"nonInferiorityType":"SUPERIORITY_OR_OTHER","pValue":"0.183","statisticalMethod":"ANOVA","paramType":"absolute difference","paramValue":"-5.73","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-14.4","ciUpperLimit":"2.97"}]}]},"adverseEventsModule":{"frequencyThreshold":"5","eventGroups":[{"id":"EG000","title":"EPAP Night","seriousNumAffected":0,"seriousNumAtRisk":19,"otherNumAffected":0,"otherNumAtRisk":19},{"id":"EG001","title":"Control Night","seriousNumAffected":0,"seriousNumAtRisk":19,"otherNumAffected":0,"otherNumAtRisk":19}]},"moreInfoModule":{"certainAgreement":{"piSponsorEmployee":false,"restrictiveAgreement":false},"pointOfContact":{"title":"Devin L. Brown, MD, MS","organization":"University of Michigan","email":"devinb@umich.edu","phone":"734-936-9075"}}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000001049","term":"Apnea"},{"id":"D000012891","term":"Sleep Apnea Syndromes"},{"id":"D000020181","term":"Sleep Apnea, Obstructive"},{"id":"D000020521","term":"Stroke"},{"id":"D000083242","term":"Ischemic Stroke"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000012120","term":"Respiration Disorders"},{"id":"D000012140","term":"Respiratory Tract Diseases"},{"id":"D000012818","term":"Signs and Symptoms, Respiratory"},{"id":"D000020919","term":"Sleep Disorders, Intrinsic"},{"id":"D000020920","term":"Dyssomnias"},{"id":"D000012893","term":"Sleep Wake Disorders"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M4051","name":"Apnea","asFound":"Apnea","relevance":"HIGH"},{"id":"M15384","name":"Sleep Apnea Syndromes","asFound":"Sleep Apnea","relevance":"HIGH"},{"id":"M21700","name":"Sleep Apnea, Obstructive","asFound":"Obstructive Sleep Apnea","relevance":"HIGH"},{"id":"M10233","name":"Ischemia","relevance":"LOW"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M16045","name":"Syndrome","relevance":"LOW"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M14647","name":"Respiration Disorders","relevance":"LOW"},{"id":"M14667","name":"Respiratory Tract Diseases","relevance":"LOW"},{"id":"M15313","name":"Signs and Symptoms, Respiratory","relevance":"LOW"},{"id":"M21932","name":"Parasomnias","relevance":"LOW"},{"id":"M22344","name":"Sleep Disorders, Intrinsic","relevance":"LOW"},{"id":"M22345","name":"Dyssomnias","relevance":"LOW"},{"id":"M15386","name":"Sleep Wake Disorders","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC08","name":"Respiratory Tract (Lung and Bronchial) Diseases"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"BXM","name":"Behaviors and Mental Disorders"}]}},"hasResults":true}